| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 生物原料(元) | 2,381,277.86 | 10,876,365.74 | 7,639,608.88 | 7,907,090.65 |
| 诊断试剂(元) | 144,506,031.98 | 414,854,503.04 | 200,676,794.52 | 509,334,159.82 |
| 诊断仪器(元) | 40,360,407.60 | 79,275,920.36 | 34,438,231.30 | 20,655,095.47 |
| 其他(元) | 16,665,596.89 | - | 6,055,393.42 | 3,354,860.03 |
| 营业成本(元) | ||||
| 生物原料(元) | 1,302,696.08 | 6,208,567.22 | 3,383,607.31 | 4,371,721.57 |
| 诊断试剂(元) | 45,478,272.37 | 142,133,497.10 | 66,047,674.60 | 205,659,592.61 |
| 诊断仪器(元) | 37,903,792.22 | 74,192,048.84 | 46,093,756.38 | 22,812,121.57 |
| 其他(元) | 4,671,745.95 | - | 8,939,829.17 | 151,560.96 |
| 毛利(元) | ||||
| 生物原料(元) | 1,078,581.78 | 4,667,798.52 | 4,256,001.57 | 3,535,369.08 |
| 诊断试剂(元) | 99,027,759.61 | 272,721,005.94 | 134,629,119.92 | 303,674,567.21 |
| 诊断仪器(元) | 2,456,615.38 | 5,083,871.52 | -11,655,525.08 | -2,157,026.10 |
| 其他(元) | 11,993,850.94 | - | -2,884,435.75 | 3,203,299.07 |
| 毛利率(%) | ||||
| 生物原料(%) | 45.29 | 42.92 | 55.71 | 44.71 |
| 诊断试剂(%) | 68.53 | 65.74 | 67.09 | 59.62 |
| 诊断仪器(%) | 6.09 | 6.41 | -33.84 | -10.44 |
| 其他(%) | 71.97 | - | -47.63 | 95.48 |
| 收入构成(%) | ||||
| 生物原料(%) | 1.17 | 2.15 | 3.07 | 1.46 |
| 诊断试剂(%) | 70.87 | 82.15 | 80.65 | 94.10 |
| 诊断仪器(%) | 19.79 | 15.70 | 13.84 | 3.82 |
| 其他(%) | 8.17 | - | 2.43 | 0.62 |
| 毛利构成(%) | ||||
| 生物原料(%) | 0.94 | 1.65 | 3.42 | 1.15 |
| 诊断试剂(%) | 86.44 | 96.55 | 108.27 | 98.51 |
| 诊断仪器(%) | 2.14 | 1.80 | -9.37 | -0.70 |
| 其他(%) | 10.47 | - | -2.32 | 1.04 |